InvestorQ : How does the recent drug approval of Zydus Cadila help the stock?
Rutuja Nigam made post

How does the recent drug approval of Zydus Cadila help the stock?

Answer
user profile image
Arti Chavan answered.
3 months ago


Zydus Cadila received approval from the US health regulator, FDA, to start clinical trials for its drug Desidustat. This drug is used to treat chemotherapy-induced anaemia, in the case of patients undergoing cancer treatment. Desidustat is currently undergoing phase-III trials for treating anaemia in chronic kidney disease patients.

Zydus Cadila mentioned the same in a regulatory filing. It is expected to initiate clinical trials of Desidustat shortly. According to Cadila, this is a serious unmet medical need. The news flow is likely to be positive for the stock but it has not been able to make a real dent on the COVID front and that is what is really driving valuations of Indian pharma companies.